Ferring Pharmaceuticals Inc: Drug Recall
Recall #D-0879-2023 · 06/12/2023
Class II: Risk
Recall Details
- Recall Number
- D-0879-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Ferring Pharmaceuticals Inc
- Status
- Terminated
- Date Initiated
- 06/12/2023
- Location
- Parsippany, NJ, United States
- Voluntary/Mandated
- N/A
- Product Quantity
- N/A
Reason for Recall
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Product Description
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03
Distribution Pattern
USA Nationwide
Other Recalls by Ferring Pharmaceuticals Inc
- Class II: Risk 03/11/2021
- Class II: Risk 03/11/2021
- Class III: Low Risk 03/02/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.